Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
A study suggests that weight loss medications like Ozempic may help ... Eli Lilly says a new trial showed the key ingredient in its popular drugs Zepbound and Mounjaro helped slash the chance ...
Ongoing trials of the next generation of weight loss drugs are revealing something unexpected: Some patients are losing too ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback